Huapont Life Sciences Co Ltd (002004) — Free Cash Flow Generation Index
Huapont Life Sciences Co Ltd (002004) has a Free Cash Flow Generation Index of 0.75x as of September 2025. Free cash flow of CN¥475.12 Million represents 1% of operating cash flow (CN¥635.17 Million). Explore reinvestment intensity of Huapont Life Sciences Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Huapont Life Sciences Co Ltd Free Cash Flow Generation Index (2002–2025)
Historical FCF Generation Index trend for Huapont Life Sciences Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see Huapont Life Sciences Co Ltd operating cash flow efficiency.
Annual Free Cash Flow Generation for Huapont Life Sciences Co Ltd (2002–2025)
Year-by-year Free Cash Flow Generation Index for Huapont Life Sciences Co Ltd. Check 002004 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.70x | CN¥1.46 Billion | CN¥2.10 Billion | CN¥638.28 Million | ▲ +69.0% |
| 2024 | 0.41x | CN¥669.02 Million | CN¥1.63 Billion | CN¥956.27 Million | ▲ +114.3% |
| 2023 | 0.19x | CN¥305.35 Million | CN¥1.59 Billion | CN¥1.28 Billion | ▼ -63.8% |
| 2022 | 0.53x | CN¥1.28 Billion | CN¥2.41 Billion | CN¥1.13 Billion | ▲ +5004.1% |
| 2021 | 0.01x | CN¥13.19 Million | CN¥1.27 Billion | CN¥1.26 Billion | ▼ -97.8% |
| 2020 | 0.48x | CN¥1.14 Billion | CN¥2.37 Billion | CN¥1.23 Billion | ▲ +54.4% |
| 2019 | 0.31x | CN¥648.66 Million | CN¥2.08 Billion | CN¥1.43 Billion | ▼ -26.5% |
| 2018 | 0.42x | CN¥809.21 Million | CN¥1.91 Billion | CN¥1.10 Billion | ▲ +165.8% |
| 2017 | -0.64x | CN¥-381.27 Million | CN¥591.40 Million | CN¥972.67 Million | ▼ -136.8% |
| 2016 | -0.27x | CN¥-139.34 Million | CN¥511.90 Million | CN¥651.24 Million | ▲ +80.9% |
| 2015 | -1.43x | CN¥-489.32 Million | CN¥342.45 Million | CN¥831.76 Million | ▼ -402.8% |
| 2014 | -0.28x | CN¥-129.58 Million | CN¥455.96 Million | CN¥585.54 Million | ▼ -227.8% |
| 2013 | -0.09x | CN¥-30.30 Million | CN¥349.51 Million | CN¥379.81 Million | ▲ +61.1% |
| 2012 | -0.22x | CN¥-57.46 Million | CN¥257.75 Million | CN¥315.21 Million | ▼ -176.4% |
| 2011 | 0.29x | CN¥39.46 Million | CN¥135.23 Million | CN¥95.77 Million | ▲ +1.4% |
| 2010 | 0.29x | CN¥22.97 Million | CN¥79.84 Million | CN¥56.87 Million | ▼ -29.0% |
| 2009 | 0.41x | CN¥50.06 Million | CN¥123.53 Million | CN¥73.46 Million | ▲ +116.8% |
| 2008 | 0.19x | CN¥21.27 Million | CN¥113.76 Million | CN¥92.49 Million | ▲ +133.0% |
| 2007 | -0.57x | CN¥-44.81 Million | CN¥79.21 Million | CN¥124.02 Million | ▼ -303.9% |
| 2006 | 0.28x | CN¥18.34 Million | CN¥66.10 Million | CN¥47.76 Million | ▲ +1758.5% |
| 2005 | -0.02x | CN¥-730.85K | CN¥43.69 Million | CN¥44.42 Million | ▼ -102.7% |
| 2004 | 0.62x | CN¥43.77 Million | CN¥70.60 Million | CN¥26.83 Million | ▲ +35.9% |
| 2003 | 0.46x | CN¥25.86 Million | CN¥56.68 Million | CN¥30.82 Million | ▲ +206.3% |
| 2002 | -0.43x | CN¥-15.83 Million | CN¥36.88 Million | CN¥52.71 Million | — |